nonarteritic anterior ischemic optic neuropathy semaglutide Associated With That Can Lead to Blindness, Mass Eye and Ear Researchers Report A new study suggests patients

Tirzepatide 15 mg discontinuation runs 6-8% in trials

However, these findings require replication, and the specific contribution of tirzepatide's dual GIP/GLP-1 mechanism remains unclear

This can be especially key for those with the condition, as over time, high blood sugar levels can lead to complications of diabetes , such as kidney failure, nerve damage, vision loss, heart problems, and more

Some people who took retatrutide reported feeling nauseous or dealt with diarrhea, constipation or vomiting

Muscle loss concerns: Research shows that roughly one-quarter to one-third of weight lost on GLP-1 agonists comes from lean body mass rather than fat